Pulmonary epithelioid haemangioendothelioma - Interferon 2-alpha treatment - Case report

Pneumonologia i Alergologia Polska

Volumn 76, Issue 4, 2008, Pages 281-285

  Radzikowska, Elzbieta ^a   Szczepulska Wójcik, Ewa ^a   Chabowski, Mariusz ^a   Oniszh, Karina ^a   Langfort, Renata ^a   Roszkowski, Kazimierz ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Interferon 2 alpha; Lung; Pulmonary epithelioid haemangioendothelioma

Indexed keywords

ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CD3 ANTIGEN; HERMES ANTIGEN; VON WILLEBRAND FACTOR;

ARTICLE; CASE REPORT; FEMALE; HEMANGIOENDOTHELIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; MIDDLE AGED; RADIOGRAPHY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANTIGENS, CD3; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; FEMALE; HEMANGIOENDOTHELIOMA, EPITHELIOID; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON ALFA-2B; LUNG NEOPLASMS; MIDDLE AGED; RADIOGRAPHY, THORACIC; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 53049085098     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Corrin B., Dewar A., Simpson C.G. Epithelioid hemangioendothelioma of the lung. Ultrastruct. Pathol. 1996; 20: 345-347.
2. Weiss S.W., Enzinger F.M. Epithelioid hemangioendothelioma: a vascular tumour often mistaken for a carcinoma. Cancer 1982; 50: 970-981.
3. Bagan P., Hassan M., Le Pimpec Barthes F. et al. Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature. Ann. Thorac. Surg. 2006; 82: 2010-2013.
4. Dail D.H., Liebow A.A., Gmelich J.T. et al. Intravascular, bronchiolar, and alveolar tumour of the lung (IVBAT). Cancer 1983; 51: 452-464.
5. Kitaichi M., Nagai S., Nishimura K. et al. Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression. Eur. Respir. J. 1998; 12: 89-96.
6. Cronin P., Arenberg D. Pulmonary epithelioid hemangioendothelioma: an unusual case and a review of the literature. Chest 2004; 125: 789-793.
7. Roudier-Pujol C., Enjolras O., Lacronique et al. Multifocal epithelioid haemangioendothelioma with partial remission after interferon a-2a treatment. Ann. Dermatol. Venerol. 1994; 121: 898: 904.
8. Kayler L.K., Merion R.M., Arenas J.D. et al. Epithelioid hemangioendothelioma of liver disseminated to the peritoneum treated with liver transplantation and interferon alpha 2B. Transplantation 2002; 74: 128-130.
9. Kumar P., Judson I., Nicholson A., Ladas C. Mediastinal haemangioma: successful treatment by alpha-2a interferon and post chemotherapy resection. J. Thorac. Cardiovasc. Surg. 2002; 124: 404-406.
10. Gordillo G.M., Onat D., Stockinger M. et al. A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation. Am. J. Physiol. Cell. Physiol 2004: 4; C866-873.
11. Boudousquie A.C., Lawce H.J., Sherman R., Olson S., Magenis R.E., Corless C.L. Complex translocation [7; 22] identified in epithelioid hemangioendothelioma. Cancer Genet Cytogenet 1996; 92: 116-121.
12. Ledson M.J., Convery R., Carty A., Evans C.C. Epitheloid haemangioendothelioma. Thorax 1999; 54: 560-561.
13. Diaz R., Segura A., Calderero V., Aparicio J., Jorda M.V., Pellin L. Central nervous system metastases of pulmonary epithelioid haemangioendothelioma. Eur. Respir. J. 2004; 23: -483.
14. Pinet C., Magnan R.M., Garbe C., Payan M.J., Vervoloet D. Aggressive form of pleural haemangioendothelioma complete relapse after chemotherapy. Eur. Respir. J. 1999; 14: 237-238.